首页 | 本学科首页   官方微博 | 高级检索  
     


The kinetics of cohesive powder de-agglomeration from three inhaler devices
Authors:Behara Srinivas Ravindra Babu  Larson Ian  Kippax Paul  Morton David A V  Stewart Peter
Affiliation:a Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia
b Malvern Instruments, Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ, UK
Abstract:

Purpose

The purpose of the current investigation is to understand the kinetics of de-agglomeration (kd) of micronised salbutamol sulphate (SS) and lactohale 300 (LH300) under varying air flow rates (30-180 l min−1) from three dry powder inhaler devices (DPIs), Rotahaler® (RH), Monodose Inhaler® (MI) and Handihaler® (HH).

Results

Cumulative fine particle mass vs. time profiles were obtained from the powder concentration, emitted mass and volume percent <5.4 μm, embedded in the particle size distributions of the aerosol at specific times. The rate of de-agglomeration (kd), estimated from non-linear least squares modelling, increased with increasing air flow rates. The kdvs. air flow rate profiles of SS and LH300 were significantly different at high air flow rates. The kd was highest from RH and lowest from MI. Differences in kd between the devices were related to device mode of operation while the differences between the materials were due to the powder bed structure.

Conclusion

This approach provided a methodology to measure the rate constant for cohesive powder de-agglomeration following aerosolisation from commercial devices and an initial understanding of the influence of device, air flow rate and material on these rate constants.
Keywords:AIC, akaike information criteria   AL, Aerolizer®     BERM, bi-exponential rise to maximum   CFPM, cumulative fine particle mass   CFPMmax, maximum cumulative fine particle mass   CFPMt, cumulative fine particle mass at time &ldquo  t&rdquo     DH, Dinkihaler®     EMt, emitted mass at time &ldquo  t&rdquo     FPMt, fine particle mass at time &ldquo  t&rdquo     HH, Handihaler®     kd, rate constant for de-agglomeration   LH300, lactohale 300   MERM, mono-exponential rise to maximum   MI, Monodose Inhaler®     RH, Rotahaler®     SS, salbutamol sulphate
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号